Updated time: 2020-10-15 16:05:00
28A-1090525
2020-10-15
USP Pending
Utilizing our approach called “natural product inspired combinatorial chemistry”, we developed new bicyclic iminosugars as New scaffolds with a varied ring size and chirality. These novel scaffolds were further modified to generate new libraries with the substitution diversity. After bio-evaluation, potent and selective human mannosidase inhibitors are found. These compounds can be cellular N-glycan modulators, which can be utilized for potentially therapeutic applications such as cancer, autoimmune disease, Alzheimer’s disease or virus. Herein, we showed out compounds are a new class of anticancer agents and also can modulate cellular N-glycosylation and cell migration.
- Using “Natural product inspired combinatorial chemistry” to develop new scaffolds, new molecules, and new libraries.
- Design and synthesis of Bicyclic iminosugar-based scaffolds with various ring size, chirality and substituent diversity.
- Using scaffolds for libraries synthesis with substituted diversity, followed by in vitro enzymatic studies and cell inhibition study or cell-based functional studies.
- Developing new scaffolds and molecules, and libraries.
- Developing Potent and selective human alfa-Golgi Mannosidase II inhibitors.
- new small molecules to apply mannosidases.
- new molecules to modulate cellular glycosylation.
- new molecules for N-glycan related diseases such as cancer, autoimmune disease, Alzheimer’s disease, virus, etc.
Wei-Chieh Cheng、Ting-Jen Cheng、Chia-Ning Shen、Wei-An Chen、Yu-Hsin Chen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Novel substituted polyhydroxylated indolizidine and pyrrolizidine analogues, preparation method and use thereof